• Index page
  • Información de interés
  • Login
  • Communities & Collections
  • Language
    Englishespañolportuguês (Brasil)
View Item 
  •   Redicuc Home
  • Producción científica y académica
  • Artículos científicos
  • View Item
  •   Redicuc Home
  • Producción científica y académica
  • Artículos científicos
  • View Item
Universidad de la Costa, CUC. Calle 58 # 55 - 66. Barranquilla, Colombia. 336 22 00. repositorioredicuc@cuc.edu.co. Corporación Universidad de la Costa.

A comprehensive care program achieves high remission rates in rheumatoid arthritis in a middle-income setting. Experience of a center of excellence in Colombia

Thumbnail
View/Open
A Comprehensive Care Program Achieves (163.9Kb)
Date
2018-03-01
Author
Santos Moreno, Pedro Ivan
Alvis Zakzuk, Nelson Jose
Villarreal Peralta, Laura
Carrasquilla Sotomayor, María
Paternina Caicedo, Angel Jose
Alvis Guzman, Nelson Rafael
Metadata
Show full item record
BASE GoogleScholar
Compartir:


Impacto

URI: http://hdl.handle.net/11323/1667
Citar con DOI: DOI: 10.1007/s00296-017-3903-2

Abstract

Management of rheumatoid arthritis (RA) in many Latin-American countries is impaired by fragmentation and scarce healthcare provision, resulting in obstacles to access, diagnosis, and treatment, and consequently in poor health outcomes. The aim of this study is to propose a comprehensive care program as a model to provide healthcare to RA patients receiving synthetic DMARDs in a Colombian setting by describing the model and its results. Health outcomes were prospectively collected in all patients entering the program. By protocol, patients are followed up during 24 months using a treat-to-target strategy with a patient-centered care (PCC) model, meaning that a patient should be seen by rheumatologist, physical and occupational therapist, physiatrist, nutritionist and psychologist, at least three times a year according to disease activity by DAS28. Otherwise, patients receive standard therapy. The incidence of remission and low disease activity (LDA) was calculated by periods of follow-up. A total of 968 patients entered the program from January 2015 to December 2016; 80.2% were women. At baseline, 41% of patients were in remission, 17% in LDA and 42% in MDS/SDA. At 24 months of follow-up, 66% were in remission, 18% in LDA and only 16% in MDS/SDA. Regarding DAS28, the mean at the beginning of the time analysis was 3.1 (SD 1.0) and after 24 months it was 2.4 (SD 0.7), showing a statistically significant improvement (p < 0.001). In all patients, the reduction of disease activity was 65% (95% CI, 58–71). Patients entering the PCC program benefited from a global improvement in disease activity in terms of DAS28.
Collections
  • Artículos científicos

Browse

All of RedicucCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

Login

Compartir en

Universidad de la Costa, CUC

  • Calle 58 # 55 - 66. Barranquilla, Colombia

  • 336 22 00

  • repositorioredicuc@cuc.edu.co

Corporación Universidad de la Costa CUC, Personería Jurídica con Resolución No. 352 del 23 de abril de 1971 y reconocida como Universidad mediante resolución 3235 del 28 de marzo de 2012 expedida por el MEN. Institución de Educación Superior sujeta a inspección y vigilancia por el Ministerio de Educación Nacional.

Enlaces institucionales:

  • Universidad de la Costa
  • Biblioteca
  • Catálogo bibliográfico
  • Recuperador Primo

Universidad de la Costa CUC.
Politica de Protección de Datos.